Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients
Hand-out
Press Releases
Shanton Pharma  
March 28, 2025

Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout

logo salamanca press

Salamanca Press

Local & Social